Scandium Canada (TSX-V:SCD) is working on a two-pronged approach to progress, as it develops the only known primary source of ...
Adial Pharmaceuticals, Inc. (NASDAQ: ADIL) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results